BMI1 has been found to be a characteristic marker of poor prognosis in patients with breast cancer, nasopharyngeal carcinoma, oesophageal squamous cell carcinoma and gastric carcinoma36,39,40. This evidence concerns the gene BMI1 and breast carcinoma.